中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2010年
3期
351-353
,共3页
黄燕娟%曾建业%黄冰%钟日胜%何二宁%马南花%冉雪莲%覃思平
黃燕娟%曾建業%黃冰%鐘日勝%何二寧%馬南花%冉雪蓮%覃思平
황연연%증건업%황빙%종일성%하이저%마남화%염설련%담사평
氨溴索%呼吸,人工%炎症%脂质过氧化作用
氨溴索%呼吸,人工%炎癥%脂質過氧化作用
안추색%호흡,인공%염증%지질과양화작용
Ambroxol%Respiration,artificial%Inflammation%Lipid peroxidation
目的 评价氨溴索预先给药对单肺通气患者炎性反应及脂质过氧化反应的影响.方法 选择开胸手术患者45例,年龄37~64岁,体重53~65 kg,ASAⅠ或Ⅱ级,随机分为3组(n=15),双肺通气组(TLV组)、单肺通气组(OLV组),单肺通气+氨溴索组(OLV+AMB组)于单肺通气前25 min开始静脉输注氨溴索1 mg/kg(100 ml,4 ml/min),TLV组和OLV组静脉输注等容量生理盐水.OLV组和OLV+AMB组于麻醉诱导前(T0)、单肺通气前即刻(T1)、单肺通气0.5 h(T2)、1 h(T3)、2 h(T4)、恢复双肺通气后1 h(T5)、2 h(T6)和术后24 h(T7)时,TLV组于上述对应时点,采集桡动脉血样,测定血清TNF-α、IL-6、IL-8浓度和SOD活性,进行WBC和中性粒细胞(PMN)计数.结果 与TLV组比较,OLV组血清IL-6、IL-8、TNF-α浓度升高,SOD活性降低,WBC和PMN计数升高(P<0.05或0.01);与OLV组比较,OLV+AMB组血清IL-6、IL-8和TNF-α浓度降低,SOD活性升高,WBC和PMN计数降低(P<0.05或0.01).结论 氨溴索1 mg/kg预先给药可减轻单肺通气患者炎性反应及脂质过氧化反应.
目的 評價氨溴索預先給藥對單肺通氣患者炎性反應及脂質過氧化反應的影響.方法 選擇開胸手術患者45例,年齡37~64歲,體重53~65 kg,ASAⅠ或Ⅱ級,隨機分為3組(n=15),雙肺通氣組(TLV組)、單肺通氣組(OLV組),單肺通氣+氨溴索組(OLV+AMB組)于單肺通氣前25 min開始靜脈輸註氨溴索1 mg/kg(100 ml,4 ml/min),TLV組和OLV組靜脈輸註等容量生理鹽水.OLV組和OLV+AMB組于痳醉誘導前(T0)、單肺通氣前即刻(T1)、單肺通氣0.5 h(T2)、1 h(T3)、2 h(T4)、恢複雙肺通氣後1 h(T5)、2 h(T6)和術後24 h(T7)時,TLV組于上述對應時點,採集橈動脈血樣,測定血清TNF-α、IL-6、IL-8濃度和SOD活性,進行WBC和中性粒細胞(PMN)計數.結果 與TLV組比較,OLV組血清IL-6、IL-8、TNF-α濃度升高,SOD活性降低,WBC和PMN計數升高(P<0.05或0.01);與OLV組比較,OLV+AMB組血清IL-6、IL-8和TNF-α濃度降低,SOD活性升高,WBC和PMN計數降低(P<0.05或0.01).結論 氨溴索1 mg/kg預先給藥可減輕單肺通氣患者炎性反應及脂質過氧化反應.
목적 평개안추색예선급약대단폐통기환자염성반응급지질과양화반응적영향.방법 선택개흉수술환자45례,년령37~64세,체중53~65 kg,ASAⅠ혹Ⅱ급,수궤분위3조(n=15),쌍폐통기조(TLV조)、단폐통기조(OLV조),단폐통기+안추색조(OLV+AMB조)우단폐통기전25 min개시정맥수주안추색1 mg/kg(100 ml,4 ml/min),TLV조화OLV조정맥수주등용량생리염수.OLV조화OLV+AMB조우마취유도전(T0)、단폐통기전즉각(T1)、단폐통기0.5 h(T2)、1 h(T3)、2 h(T4)、회복쌍폐통기후1 h(T5)、2 h(T6)화술후24 h(T7)시,TLV조우상술대응시점,채집뇨동맥혈양,측정혈청TNF-α、IL-6、IL-8농도화SOD활성,진행WBC화중성립세포(PMN)계수.결과 여TLV조비교,OLV조혈청IL-6、IL-8、TNF-α농도승고,SOD활성강저,WBC화PMN계수승고(P<0.05혹0.01);여OLV조비교,OLV+AMB조혈청IL-6、IL-8화TNF-α농도강저,SOD활성승고,WBC화PMN계수강저(P<0.05혹0.01).결론 안추색1 mg/kg예선급약가감경단폐통기환자염성반응급지질과양화반응.
Objective To investigate the effect of ambroxol pretreatment on the inflammatory response and lipid peroxidation during one-lung ventilation (OLV) .Methods Forty-five ASA I or II patients aged 37-64 yr weighing 53-65 kg undergoing thoracotomy under general anesthesia were randomly divided into 3 groups ( n = 15 each): group A two-lung ventilation (TLV); group B OLV and group C ambroxol 1 mg/kg + OLV. Anesthesia was induced with midazolam, fentanyl, propofol and atracurium and maintained with propofol infusion and intermittent iv boluses of fentanyl and atracurium. The patients were mechanically ventilated (VT8-10 ml/kg, RR 12 bpm during TLV, VT 6-7 ml/kg, RR 16 bpm during OLV, I: E 1:2, FiO2 100% ). In group C ambroxol 1 mg/kg in normal saline ( NS) 100 ml was infused at 25 min before OLV (infusion rate 4 ml/min) , while in group A and B equal volume of NS was infused instead of ambroxol. Blood samples were obtained from radial artery before induction of anesthesia and OLV (T0.1 ) and at 0.5, 1, 2 h of OLV (T2-4 ) and 1, 2 h of TLV (T5,6 ) and at 24 h after operation (T7) in group B and C for determination of serum SOD activity and TNF-α, IL-6 and IL-8 concentrations and WBC and neutrophil granulocyte counts. The same indexes were detected in group A at the corresponding time points.Results Serum SOD activity was significantly lower and serum TNF-α, IL-6 and IL-8 concentrations and WBC and neutrophil granulocyte counts were significantly higher in group B than in group A. Serum SOD activity was significantly higher and serum TNF-a, IL-6 and IL-8 concentrations and WBC and neutrophil granulocyte counts were significantly lower in group C than in group B. Conclusion Pretreatment with ambroxol 1 mg/kg can inhibit inflammatory response and lipid peroxidation during OLV.